
About Medipaams
Medipaams is a Healthcare company. Pharmaceutical manufacturing and distribution of medicines for domestic and international markets. Its Indian entity Medipaams India Private Limited reported revenue of βΉ4.52 Cr. Medipaams offers products and services including Injectables and Tablets. Its focus areas include Pharmaceuticals, Medicine Manufacturing, Drug Distribution and International Export.
Company details
Medipaams is recognized as a Mumbai-based pharmaceutical company that has maintained a market presence since 1982. It specializes in the development, manufacturing, and distribution of high-quality medicines for both domestic and international markets. Products are designed to enhance the health and wellbeing of people globally, with a commitment to innovative processes and adherence to Good Manufacturing Practices. Raw materials of varied quality are utilized, and the company ensures affordability and on-time supply through its extensive network across Africa, Asia, Latin America, and other regions. Quality assessments are regularly performed by qualified personnel to uphold efficacy and standards.
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website medipaams.com
- Social Facebook Instagram
- Legal Name Medipaams India Pvt. Ltd
- Date of Incorporation 29 Jun, 2005
- Jurisdiction Mumbai, Maharashtra, India
- Indian entity revenue₹4.52 Cr
FY 2024 · +13% YoY
- Indian entity net profit₹1.4 Lakh
FY 2024 · 0% margin
- Indian entity EBITDA₹2.4 Lakh
FY 2024 · 1% margin
Associated legal entities of Medipaams
Medipaams operates through Medipaams India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Medipaams India Private Limited CIN U51397MH2005PTC154336 | Active | 29 Jun 2005 | Mumbai, Maharashtra | ₹4.5 Cr | 2 | View details |
Products & Services of Medipaams
Medipaams offers a comprehensive portfolio of products and services, including Injectables and Tablets.
Injectables are manufactured and distributed for various medical applications to support patient care in healthcare settings
Tablets are produced and supplied for general and critical care purposes, ensuring accessibility in domestic and global markets
Board of directors of Medipaams India Private Limited (Medipaams)
Medipaams India Private Limited is the primary company behind Medipaams. The board of Medipaams India Private Limited currently have 2 directors; the longest-serving is Alpesh Munani Popatlal, appointed in 2005. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Alpesh Munani Popatlal DIN 01206597 | Director | 03 Aug 2005 | 21 yrs 3 mo | Medipaams India Private Limited |
| Abhi Alpesh Munani DIN 08438754 | Director | 18 May 2020 | 6 yrs 6 mo | Medipaams India Private Limited |
Financials of Medipaams
Figures of Medipaams India Private Limited, the primary company behind Medipaams, for FY 2024. Revenue was ₹4.52 Cr (+13% year on year). Net profit was ₹1.4 Lakh (0% margin). EBITDA was ₹2.4 Lakh (1% margin). Revenue has grown at a compounded annual rate of +41% over three years and +17% over five years.
- ₹4.52 CrRevenue · FY 2024 · +13% YoY
- ₹1.4 LakhNet profit · 0% margin
- ₹2.4 LakhEBITDA · 1% margin
- ₹1 LakhPaid-up capital
- +41%Revenue CAGR, 3 years
- +17%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Medipaams India Private Limited are on its company page.
Detailed financial statements for Medipaams
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Medipaams
The primary company behind Medipaams, Medipaams India Private Limited, reported revenue of βΉ4.52 Cr for FY 2024, up 13% year on year.
Medipaams is recognized as a Mumbai-based pharmaceutical company that has maintained a market presence since 1982. It specializes in the development, manufacturing, and distribution of high-quality medicines for both domestic and international markets. Products are designed to enhance the health and wellbeing of people globally, with a commitment to innovative processes and adherence to Good Manufacturing Practices. Raw materials of varied quality are utilized, and the company ensures affordability and on-time supply through its extensive network across Africa, Asia, Latin America, and other regions. Quality assessments are regularly performed by qualified personnel to uphold efficacy and standards.
Medipaams offers Injectables and Tablets.
Medipaams operates through Medipaams India Private Limited.
The legal entities of Medipaams currently have 2 directors, including Alpesh Munani Popatlal, Abhi Alpesh Munani.